(Q57632250)

English

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus

scientific article published on 01 July 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

type-1 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

Claus H. Gravholt

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

B Nyholm

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

L Orskov

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

K Y Hove

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

K G Alberti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

C Moyses

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

O Kolterman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

O Schmitz

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

935-941

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Dose-response for glucagonostatic effect of amylin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Glucagon physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Glucagon and its family revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

The essential role of glucagon in the pathogenesis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Glucagon: Role in the Hyperglycemia of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Persistent effect of sustained hyperglucagonemia on glucose production in man

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Evidence for an important role of changes in rather than absolute concentrations of glucagon in the regulation of glucose production in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

In vitro autoradiographic localization of amylin binding sites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Role of amylin in nutrient intake - animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Leptin: the tale of an obesity gene

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Effects of glucagon on free fatty acid metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Amylin injection causes elevated plasma lactate and glucose in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Identifiers

10.1016/S0026-0495(99)90232-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57632250&oldid=2154440157"